The Toronto-Dominion Bank
TD
Bank of Montreal
BMO
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Canadian Imperial Bank of Commerce
CM
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.